Pharmaxis Ltd (AU:SNT) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Syntara Limited, an ASX-listed company, has attributed recent trading activity in its securities to investor anticipation of upcoming interim trial data on its SNT-5055 drug, as well as increased coverage by a major broker. The company plans to release the data after peer review at a scientific meeting and maintains that the information remains confidential. Despite market fluctuations, Syntara confirms its compliance with ASX listing rules.
For further insights into AU:SNT stock, check out TipRanks’ Stock Analysis page.
